PTX is lining up for a huge series of announcements with two clinical stage oncology drugs in the pipeline. PTX -200 now has 3 x 1b/2 trials in progress and PTX-100 travelling behind. MC A $19 mill with A $9 mill cash in hand good results should propel the SP north.
